RAPP compared with SEPN: revenue, margins and what each company keeps, and the suppliers and customers both name

RAPPRapport Therapeutics, Inc.

Mkt capRevenueRevenue

SEPNSepterna, Inc.

Mkt capRevenueRevenue

Compare

RAPPRapport Therapeutics, Inc.

SEPNSepterna, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

RAPP, solidSEPN, dashed

Supply-chain overlap

Revenue flow

RAPP: latest quarter is a loss; flow not drawable. SEPN: latest quarter is a loss; flow not drawable.Method ›

RAPPRapport Therapeutics, Inc.

25.06▲+3.50%· post 24.57

Mkt cap$1.2BRevenue$20MQ1 FY26Revenue—

SEPNSepterna, Inc.

43.98▼−2.76%· post 43.98

ClosedOct 30 '26

Mkt cap$2.0BRevenue$27MQ2 FY26Revenue$46MFY25

Compare

ClosedOct 30 '26

RAPPRapport Therapeutics, Inc.

SEPNSepterna, Inc.

25.06▲+3.50%post 24.57

Price

43.98▼−2.76%post 43.98

$1.2B

Mkt cap

$2.0B

Q1 FY26$20M

Revenue

$27MQ2 FY26

—

Revenue

$46MFY25

RAPP25.06▲+3.50%vsSEPN43.98▼−2.76%ClosedOct 30 '26

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only RAPP 3

—Janssen Pharmaceuticalunlistedsupplier

—NeuroPaceunlistedsupplier

—Tenacia Biotechnology (Hong Kong)unlistedcustomer

Shared 0

No shared counterparties.

Only SEPN 2

VRTXVertex Pharmaceuticals Incorporated ("Vertex")customer

—Novounlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR